IMAX Corporation

NYSE:IMAX Rapport sur les actions

Capitalisation boursière : US$1.9b

IMAX Croissance future

Future contrôle des critères 3/6

IMAX devrait augmenter ses bénéfices et son chiffre d'affaires de 34.1% et de 7.6% par an respectivement. Le BPA devrait croître de de 27.5% par an. Le rendement des capitaux propres devrait être 16.4% dans 3 ans.

Informations clés

34.1%

Taux de croissance des bénéfices

27.54%

Taux de croissance du BPA

Entertainment croissance des bénéfices17.5%
Taux de croissance des recettes7.6%
Rendement futur des capitaux propres16.39%
Couverture par les analystes

Good

Dernière mise à jour04 May 2026

Mises à jour récentes de la croissance future

Recent updates

IMAX: Global Premium Footprint Expansion Will Shape Future Earnings Power

The analyst price target for IMAX edges higher to about $41.09 from $41.00 as analysts incorporate mixed target moves across firms, modest adjustments to revenue growth and margin assumptions, and slightly higher future P/E expectations. Analyst Commentary Recent Street research on IMAX presents a mixed picture, with several firms lifting price targets while a smaller group trims expectations and highlights areas of risk.

IMAX: Premium Theatrical Formats And Strong Box Office Will Drive Future Upside

The IMAX analyst price target edges higher to about $45.27 from $45.00, as analysts factor in recent target raises tied to strong Q4 results, higher box office activity, robust system installs, and expectations for continued importance within the global theatrical ecosystem. Analyst Commentary Recent Street research on IMAX clusters around higher price targets and generally positive reactions to the latest quarterly results, box office trends, and system installation activity.

IMAX: Future Earnings Base And Global Footprint Frame Balanced Opportunity And Risk

Narrative Update: IMAX Analyst Price Target Shift The analyst price target for IMAX has moved to $41.00. Analysts cite record share gains, accelerating international expansion, strong Q4 and full-year revenue and margins, and continued outperformance versus consensus as key factors influencing their updated views.

IMAX: Record Box Office And Premium Format Position Will Support Future Upside

The analyst price target for IMAX is raised by about $1 to $45.00, as analysts factor in higher margin expectations, a lower assumed future P/E multiple, and recent research citing strong quarterly results, record box office driven revenue, and a stronger position in the global theatrical ecosystem. Analyst Commentary Recent research updates show a cluster of target price increases for IMAX, with analysts reacting to reported results, box office trends, and the company’s role in premium theatrical formats.

IMAX: Future Earnings Base And International Footprint Suggest Balanced Opportunity And Risk

The Analyst Price Target for IMAX has increased from $22.04 to $41.00. This reflects analysts' views that recent record revenue, strong margins, higher box office activity and an expanding international footprint support a higher assumed profit margin and P/E multiple in updated models.

IMAX: Live Sports And Content Partnerships Will Support Future Upside

Analysts have maintained their $47.00 price target on IMAX, citing updated assumptions around discount rate, revenue growth, profit margin, and a higher future P/E multiple. They also highlight broader sector risks such as high development costs, dependence on single assets, and limited near term catalysts in comparable coverage.

IMAX: Future Slate And Execution Will Support Expanded Premium Format Opportunities

Analysts have inched their price target for IMAX higher to approximately US$44.09 from about US$43.73, reflecting updated assumptions around revenue growth, profit margins and future P/E levels. Analyst Commentary Analysts have updated their IMAX models around revenue, margins and future P/E levels, which feeds directly into the small lift in the price target to about US$44.09.

IMAX: Future Slate And Profit Execution Will Support Measured Upside Potential

Analysts have lifted their IMAX fair value estimate from about US$38.81 to roughly US$43.73 per share, citing updated assumptions for revenue growth, profit margins and a lower future P/E that together support a higher price target. Analyst Commentary Analysts reviewing IMAX after the updated fair value estimate are split between what could support the higher valuation and what might limit upside if execution falls short.

IMAX Corporation: Strong Network Effect And Visible Growth Ahead

Jan 09

IMAX: Premium Screens And Local Language Hits Will Support Future Upside

Analysts have raised their price target on IMAX to $40 from $36, citing record Q3 global box office results, an increasing market share, strong local language titles, and faster-than-expected network expansion in markets with above-average revenue per screen. Analyst Commentary Bullish analysts point to IMAX's recent record Q3 global box office results and its second highest quarterly gross as key supports for their updated views, highlighting what they see as solid execution across the business.

IMAX: Expanding Premium Network Will Drive Stronger Box Office Performance

Analysts have lifted their price target on IMAX to approximately $47 from about $38, citing accelerating network expansion into higher revenue markets, record and resilient box office performance, and an expectation for stronger, more profitable growth that, in their view, supports a lower forward earnings multiple versus historical levels. Analyst Commentary Bullish analysts have recently highlighted IMAX as one of the stronger execution stories in the theatrical ecosystem, pointing to a mix of box office outperformance, premium market exposure, and disciplined capital deployment as key supports for higher valuation.

IMAX: Future Slate And Premium Screen Expansion Will Drive Measured Performance

We raise our IMAX price target to approximately $39 from about $37, as analysts highlight record Q3 box office performance, accelerating high value screen expansion, and a robust Q4 film slate that together support modestly stronger growth and valuation assumptions. Analyst Commentary Recent Street commentary on IMAX has tilted clearly positive, with multiple firms raising price targets in response to stronger than expected operating trends and an improving growth outlook.

IMAX: Future Box Office Releases And Network Expansion Will Shape Performance

IMAX's analyst price target has increased significantly, rising from $36 to $37 per share to $40 to $42 per share, as analysts cite strong quarterly box office results, ongoing network expansion, and promising upcoming film releases as key drivers of growth. Analyst Commentary Recent updates from street research provide insights into the positive momentum behind IMAX's upgraded price targets, as well as areas of continued scrutiny among analysts.

IMAX: Accelerating Network Expansion Will Drive Global Box Office Performance

The analyst consensus price target for IMAX has increased from approximately $36.45 to $37.18. Analysts highlight strong box office performance and accelerating network expansion as key drivers for the upward revision.

North America And Japan Installations Will Strengthen Premium Entertainment

Analysts have raised their price target for IMAX from approximately $34.36 to $36.45. They cite stronger box office performance, accelerating network expansion, and improved margins as key factors supporting the higher valuation.

North America And Japan Installations Will Strengthen Premium Entertainment

IMAX's analyst price target has been raised from $31 to $38, reflecting higher expected margins and valuation multiples according to analysts. Analyst Commentary Analyst sentiment toward IMAX has recently shifted, leading to an upward revision of the company's price target.

Earnings Tell The Story For IMAX Corporation (NYSE:IMAX) As Its Stock Soars 25%

Sep 09
Earnings Tell The Story For IMAX Corporation (NYSE:IMAX) As Its Stock Soars 25%

Is Now An Opportune Moment To Examine IMAX Corporation (NYSE:IMAX)?

Aug 04
Is Now An Opportune Moment To Examine IMAX Corporation (NYSE:IMAX)?

An Intrinsic Calculation For IMAX Corporation (NYSE:IMAX) Suggests It's 32% Undervalued

Jun 13
An Intrinsic Calculation For IMAX Corporation (NYSE:IMAX) Suggests It's 32% Undervalued

Market Participants Recognise IMAX Corporation's (NYSE:IMAX) Earnings Pushing Shares 25% Higher

May 17
Market Participants Recognise IMAX Corporation's (NYSE:IMAX) Earnings Pushing Shares 25% Higher

IMAX's (NYSE:IMAX) Soft Earnings Are Actually Better Than They Appear

May 02
IMAX's (NYSE:IMAX) Soft Earnings Are Actually Better Than They Appear

Should You Investigate IMAX Corporation (NYSE:IMAX) At US$22.45?

Apr 19
Should You Investigate IMAX Corporation (NYSE:IMAX) At US$22.45?

Here's What's Concerning About IMAX's (NYSE:IMAX) Returns On Capital

Apr 04
Here's What's Concerning About IMAX's (NYSE:IMAX) Returns On Capital

We Think IMAX (NYSE:IMAX) Can Stay On Top Of Its Debt

Mar 15
We Think IMAX (NYSE:IMAX) Can Stay On Top Of Its Debt

IMAX Corporation: Unlocking Asymmetric Gains In Premium Cinema

Mar 09

Is Now The Time To Look At Buying IMAX Corporation (NYSE:IMAX)?

Jan 08
Is Now The Time To Look At Buying IMAX Corporation (NYSE:IMAX)?

IMAX Corporation: Overseas Growth Opportunities

Dec 24

IMAX (NYSE:IMAX) Has Some Difficulty Using Its Capital Effectively

Dec 10
IMAX (NYSE:IMAX) Has Some Difficulty Using Its Capital Effectively

IMAX Corporation (NYSE:IMAX) Shares Could Be 44% Below Their Intrinsic Value Estimate

Nov 23
IMAX Corporation (NYSE:IMAX) Shares Could Be 44% Below Their Intrinsic Value Estimate

After Leaping 26% IMAX Corporation (NYSE:IMAX) Shares Are Not Flying Under The Radar

Nov 07
After Leaping 26% IMAX Corporation (NYSE:IMAX) Shares Are Not Flying Under The Radar

Here's Why IMAX (NYSE:IMAX) Can Manage Its Debt Responsibly

Oct 31
Here's Why IMAX (NYSE:IMAX) Can Manage Its Debt Responsibly

If EPS Growth Is Important To You, IMAX (NYSE:IMAX) Presents An Opportunity

Oct 13
If EPS Growth Is Important To You, IMAX (NYSE:IMAX) Presents An Opportunity

IMAX Corporation: Undervalued Relative To Revenue Growth And Margin Expansion Potential

Oct 10

When Should You Buy IMAX Corporation (NYSE:IMAX)?

Sep 30
When Should You Buy IMAX Corporation (NYSE:IMAX)?
User avatar

Calculated Global Expansion And Innovative Content Slate Set To Propel Growth

IMAX's strategic expansions and landmark deals in global markets promise substantial revenue growth through new installations and high-profile film releases.

Returns On Capital At IMAX (NYSE:IMAX) Paint A Concerning Picture

Aug 23
Returns On Capital At IMAX (NYSE:IMAX) Paint A Concerning Picture

IMAX Corporation: Upbeat Mid-Term Outlook After Great Q2 Signings

Jul 30

Pinning Down IMAX Corporation's (NYSE:IMAX) P/S Is Difficult Right Now

Jul 26
Pinning Down IMAX Corporation's (NYSE:IMAX) P/S Is Difficult Right Now

Is IMAX (NYSE:IMAX) A Risky Investment?

Jun 19
Is IMAX (NYSE:IMAX) A Risky Investment?

Is It Too Late To Consider Buying IMAX Corporation (NYSE:IMAX)?

May 22
Is It Too Late To Consider Buying IMAX Corporation (NYSE:IMAX)?

IMAX Corporation: Good Reasons To Be Bullish

Apr 08

IMAX Corporation Just Recorded A 12% EPS Beat: Here's What Analysts Are Forecasting Next

Mar 01
IMAX Corporation Just Recorded A 12% EPS Beat: Here's What Analysts Are Forecasting Next

Prévisions de croissance des bénéfices et des revenus

NYSE:IMAX - Estimations futures des analystes et données financières antérieures (USD Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/2028501891371827
12/31/20274729912916610
12/31/2026442749714511
3/31/20264053790124N/A
12/31/20254103585127N/A
9/30/20253784064109N/A
6/30/2025362332977N/A
3/31/2025360254089N/A
12/31/2024352263071N/A
9/30/2024346231963N/A
6/30/2024358211757N/A
3/31/202436726-926N/A
12/31/2023375252659N/A
9/30/2023387254371N/A
6/30/202335242148N/A
3/31/2023328-71142N/A
12/31/2022301-23-1517N/A
9/30/2022311-15-426N/A
6/30/2022299-15-718N/A
3/31/2022276-21-713N/A
12/31/2021255-22-126N/A
9/30/2021202-54-25-12N/A
6/30/2021183-93-29-19N/A
3/31/2021141-109-50-40N/A
12/31/2020137-144-32-23N/A
9/30/2020205-104-28-8N/A
6/30/2020254-48-821N/A
3/31/2020350-115697N/A
12/31/201939647N/A90N/A
9/30/201938030N/A109N/A
6/30/201937626N/A112N/A
3/31/201937023N/A94N/A
12/31/201837423N/A110N/A
9/30/201839126N/A90N/A
6/30/201840820N/A95N/A
3/31/201839711N/A101N/A
12/31/20173812N/A85N/A
9/30/20173626N/A96N/A
6/30/201734910N/A79N/A
3/31/201735318N/A72N/A
12/31/201637629N/A78N/A
9/30/201638942N/A87N/A
6/30/201638848N/A102N/A
3/31/201640466N/A83N/A
12/31/201537455N/A84N/A
9/30/201535753N/A57N/A
6/30/201533250N/A70N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de IMAX ( 34.1% par an) est supérieure au taux d'épargne ( 3.5% ).

Bénéfices vs marché: Les bénéfices de IMAX ( 34.1% par an) devraient croître plus rapidement que le marché US ( 16.1% par an).

Croissance élevée des bénéfices: Les bénéfices de IMAX devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de IMAX ( 7.6% par an) devrait croître plus lentement que le marché de US ( 11.3% par an).

Croissance élevée des revenus: Le chiffre d'affaires de IMAX ( 7.6% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de IMAX devrait être faible dans 3 ans ( 16.4 %).

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y

Analyse de l'entreprise et données financières

DonnéesDernière mise à jour (heure UTC)
Analyse de l'entreprise2026/05/05 08:05
Cours de l'action en fin de journée2026/05/05 00:00
Les revenus2026/03/31
Revenus annuels2025/12/31

Sources de données

Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.

PaquetDonnéesCadre temporelExemple de source américaine *
Finances de l'entreprise10 ans
  • Compte de résultat
  • Tableau des flux de trésorerie
  • Bilan
Estimations consensuelles des analystes+3 ans
  • Prévisions financières
  • Objectifs de prix des analystes
Prix du marché30 ans
  • Cours des actions
  • Dividendes, scissions et actions
Propriété10 ans
  • Actionnaires principaux
  • Délits d'initiés
Gestion10 ans
  • L'équipe dirigeante
  • Conseil d'administration
Principaux développements10 ans
  • Annonces de l'entreprise

* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.

Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.

Modèle d'analyse et flocon de neige

Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.

Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.

Indicateurs de l'industrie et du secteur

Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.

Sources des analystes

IMAX Corporation est couverte par 20 analystes. 11 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.

AnalysteInstitution
Marla BackerAscendiant Capital Markets LLC
David McFadgenATB Cormark Historical (Cormark Securities)
Patrick ShollBarrington Research Associates, Inc.